Navigation Links
QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten
Date:7/28/2014

52;rsorge), Angewandte Testung (Forensik, Veterinärdiagnostik und Lebensmitteltestung), Pharma (pharmazeutische und biotechnologische Unternehmen) sowie Akademische Forschung (Life Science Forschung). Stand 31. März 2014 beschäftigte QIAGEN weltweit über 4.000 Mitarbeiter an mehr als 35 Standorten. Weitere Informationen über QIAGEN finden Sie unter http://www.qiagen.com/.

Über AstraZeneca 

AstraZeneca ist ein globales, innovationsorientiertes biopharmazeutisches Unternehmen mit dem Schwerpunkt auf der Erforschung, Entwicklung und Kommerzialisierung verschreibungspflichtiger Arzneimittel, vorwiegend für Herzkreislauf-, Stoffwechsel-, Atemwegs-, Entzündung-, Autoimmun-, Krebs-, Infektions- und neurologische Erkrankungen. AstraZeneca ist in über 100 Ländern vertreten, und seine innovativen Medikamente werden von Millionen von Patienten in aller Welt benutzt. Weitere Informationen finden Sie unter: http://www.astrazeneca.com.

Einige der Angaben in dieser Pressemitteilung können im Sinne von Paragraph 27A des U.S. Securities Act (US-Aktiengesetz) von 1933 in ergänzter Fassung und Paragraph 21E des U.S. Securities Exchange Act (US-Aktienhandelsgesetz) von 1934 in ergänzter Fassung als zukunftsgerichtete Aussagen ("forward-looking statements") gelten. Soweit in dieser Meldung zukunftsgerichtete Aussagen über QIAGENs Produkte, Märkte, Strategie und operative Ergebnisse gemacht werden, einschließlich aber nicht begrenzt auf die zu erwartenden operativen Ergebnisse, neue Produktentwicklungen, neue Produkteinführungen, regulatorische Einreichungen und Finanzplanungen, geschieht dies auf der Basis derzeitiger Erwartungen und Annahmen, die mit gewissen Unsicherheiten und Risiken verbunden sind. Dazu zählen unter anderem: Risiken im Zusammenhang mit Wachstumsmanagement und internat
'/>"/>

SOURCE Qiagen
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
3. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
4. QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows
5. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
6. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
7. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
8. Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market
9. Financial Results, Appointments, Earnings Conferences, and Partnerships - Research Report on New Oriental Education & Technology, Acacia Research, DeVry, Capella Education, and Qiagen NV
10. QIAGEN Offers Clinical Labs Early Access to New Ingenuity Solution for Streamlined Interpretation of Patient Sequencing Data
11. Maverix Biomics Forms Strategic Co-Marketing Alliance with QIAGEN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... , July 4, 2015 ... for patients with unresectable metastatic colorectal cancer in ... that organ Patients with unresectable metastatic ... the liver experienced the greatest improvement in Progression-Free ... of SIR-Spheres Y-90 resin microspheres to a current ...
(Date:7/3/2015)... HUATULCO, Mexico , July 3, 2015 ... targeting the epidemics of hypertension, diabetes and thyroid disorders ... online educational platforms and a major conference dedicated to ... Manage Diabetes Online , Manage Hypertension ... each developed and operated by EXCEMED - ...
(Date:7/2/2015)... 3 juillet 2015 BGI a annoncé aujourd,hui ... de l,ADN situé à Hong Kong ... College of Pathologists  (Collège des pathologistes américains, ou ... Hong Kong constituent le premier laboratoire ... la certification du CAP en Chine, car il ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... 23 Neurobiological Technologies, Inc. (Nasdaq: NTII ) ("NTI") ... extraordinary dividend of $0.18 per share of common stock, which ... record as of November 30, 2009. The December 9, 2009 ... pursuant to a plan of complete liquidation and dissolution and ...
... Calif., Nov. 23 Advanced Sterilization Products (ASP), ... today the acquisition by its French affiliate, Apsis ... of innovative disinfection processes and technologies to prevent ... disclosed. , Gloster Europe designs and markets ...
Cached Medicine Technology:Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2
(Date:7/3/2015)... ... July 03, 2015 , ... Brendon Burchard's new ... a buzz of media attention. In an effort to spread the news, a ... , "These days many people are feeling overwhelmed by stress and fatigue," reports ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. E. Smith, the only ... lead a national chief nursing officer recruitment for Jane Phillips Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/3/2015)... MO (PRWEB) , ... July 03, 2015 , ... Talcum ... website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as the ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning information. ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a ... features the latest and coolest technology products available to consumers. Amanda Forstrom, a technology ... these selfie sticks are great for documenting memories. , Almost every smartphone has an ...
Breaking Medicine News(10 mins):Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... ... the American Heart Association,s PTES campaign to raise funds and awareness for stroke prevention. We ... risk of stroke. Doctors Community Hospital will be onsite at the walk-a-thon providing free health ... Bowie, MD (PRWEB) ...
... A drug whose clinical benefit in treating multiple sclerosis was ... Food and Drug Administration on January 22 and is now ... is the first therapy for multiple sclerosis that can be ... to treat impaired walking, a debilitating symptom of the disease ...
... ... course this past March, and are on their way to becoming the first iPad developers ... ... ), the leader in online and OnDemand iPhone and iPad programming and marketing training, has ...
... Amphora Research Systems ... the revolutionary Apple iPad. , ... (PRWEB) April 5, 2010 -- Amphora Research Systems is delighted to announce the ... ,"Science often happens in places where using a Desktop PC or Laptop is inconvenient, but ...
... MONDAY, April 5 (HealthDay News) -- Researchers report that they,ve ... a finding that offers a possible new avenue toward a ... moment, there,s no way to know whether the research will ... enemy. , Still, the findings do give scientists an idea ...
... ... eco-friendly and affordable Robby Wash high efficiency laundry detergent balls. One Robby Wash hypoallergenic laundry ... saves more than $100 annually. The Robby Wash has been used for years in Europe ... ...
Cached Medicine News:Health News:Bowie/Mitchellville (MD) Alumni Chapter of Kappa Alpha Psi Hosts "Power to End Stroke" Walk-a-thon in Glenn Dale, Maryland 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 2Health News:Clinical benefit of multiple sclerosis drug discovered at Rush University Medical Center 3Health News:First iPad App Developers Graduate from Around the Globe: Ready to Show Their New Apps 2Health News:Amphora's PatentSafe Electronic Laboratory Notebook Fully Supported on the Apple iPad 2Health News:Scientists Find Clues to How the Body Fights Off HIV 2Health News:Robby Wash High Efficiency Laundry Detergent Offers 25% off Coupon – Replaces 75 lbs. of Traditional Laundry Detergent Saving $100 Annually 2Health News:Robby Wash High Efficiency Laundry Detergent Offers 25% off Coupon – Replaces 75 lbs. of Traditional Laundry Detergent Saving $100 Annually 3
... The eNclose Anastomosis ... specifically to obviate the ... of the aorta. The ... the surgeon with a ...
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, Thumb Screw Control; in Titanium....
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
Medicine Products: